No Data
No Data
No Data
Pharmaniaga Returns to the Black After Two Quarters of Losses
Pharmaniaga Bhd returned to the black after two consecutive quarters of losses, thanks to higher revenue and cost control measures that lowered expenses.
Astellas Pharma Inc. (ALPMF) Q2 2023 Earnings Call Transcript Summary
The following is a summary of the Astellas Pharma Inc. (ALPMF) Q2 2023 Earnings Call Transcript:Financial Performance:Astellas Pharma reported a revenue decrease of 2% YoY due to Lexiscan generics' im
Pharmaniaga Says It Is Confident of Financial Recovery After Auditors Again Flag Going-concern Issues
KUALA LUMPUR (May 10): Pharmaniaga Bhd (KL:PHARMA), whose weak financials have just been flagged by its independent auditor for a second consecutive year, assures shareholders that it is committed to financial recovery and has made “strong and steady progress” on it.
Pharmaniaga COO Mohamed Iqbal Abdul Rahman Retires After 13 Years
Mohamed Iqbal Abdul Rahman has retired as Pharmaniaga Berhad chief operating officer (COO) effective immediately, ending his 13-year tenure with the company.
Pharmaniaga Trims Loss in Q4 2024
Pharmaniaga (KLSE:PHARMA) incurred a loss attributable to owners of 32.7 million ringgit in the fourth quarter ended Dec. 31, 2023, much lower than 644.4 million ringgit a year earlier. Loss per share
Pharmaniaga in the red for second straight year, records 4Q loss on lower revenue
Pharmaniaga Bhd logged a net loss of RM32.72 million for the final quarter of 2023, as revenue fell on lower sales from its concession business.
No Data